Fig. 4From: Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical dataDiagnostic value of PIVKA-II in differentiating early-stage HCC from cirrhosis and hepatitis. a, b Levels of AFP and PIVKA-II in patients with early-stage HCC, cirrhosis and hepatitis. c, d, e ROC curve for PIVKA-II in differentiating early-stage HCC from cirrhosis and non-HCC patients. A + P: logAFP + 4.6*logPIVKA-II. ****: <0.0001Back to article page